Finerenone reduces Incidence of Heart Failure in Diabetics with Kidney Disease

被引：0
|
作者：
Franke, Katharina
机构：
来源：
AKTUELLE KARDIOLOGIE | 2022年 / 11卷 / 03期
关键词：
D O I：
10.1055/a-1826-4716
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Der im Februar 2022 in Europa zugelassene selektive nichtsteroidale Mineralokortikoid-Rezeptor-Antagonist Finerenon hat gunstige Auswirkungen auf kardiorenale Endpunkte, wie vor Kurzem in der FIDELIO-DKD und in der FIGARO-DKD-Studie gezeigt werden konnte. Eine praspezifizierte Post-hoc-Analyse der FIGARO-DKD-Studie ergab jetzt insbesondere auch protektive Wirkungen der Substanz im Hinblick auf verschiedene Herzinsuffizienz-Endpunkte.
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] Unentangling Heart Failure From Kidney Outcomes With Finerenone Insights From the FINEARTS-HF Trial
    Kaul, Sanjay
    Hiremath, Swapnil
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (02) : 169 - 172
  • [32] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Rosenstock, Jordan L.
    Gilles, Emmanuelle
    Geller, Ari B.
    Panagopoulos, Georgia
    Mathew, Staicy
    Malieckal, Deepa
    DeVita, Maria V.
    Michelis, Michael F.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (04) : 1049 - 1054
  • [33] Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease
    Jordan L. Rosenstock
    Emmanuelle Gilles
    Ari B. Geller
    Georgia Panagopoulos
    Staicy Mathew
    Deepa Malieckal
    Maria V. DeVita
    Michael F. Michelis
    International Urology and Nephrology, 2010, 42 : 1049 - 1054
  • [34] Prevalence and Incidence of Chronic Kidney Disease in US Adult Type 2 Diabetics
    Sun, Gordon H.
    Bell, Kelly F.
    Kalsekar, Iftekar
    Anene, Ayanna
    Bentley, Tanya G. K.
    DIABETES, 2014, 63 : A357 - A358
  • [35] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
  • [36] Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial
    Filippatos, Gerasimos
    Pitt, Bertram
    Agarwal, Rajiv
    Farmakis, Dimitrios
    Ruilope, Luis M.
    Rossing, Peter
    Bauersachs, Johann
    Mentz, Robert J.
    Kolkhof, Peter
    Scott, Charlie
    Joseph, Amer
    Bakris, George L.
    Anker, Stefan D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 996 - 1005
  • [37] FINERENONE REDUCES INTRINSIC ARTERIAL STIFFNESS IN A HYPERTENISVE NON-DIABETIC RAT MODEL OF CHRONIC KIDNEY DISEASE
    Gil Ortega, M.
    Vega Martin, E.
    Martin Ramos, M.
    Gonzalez Blazquez, R.
    Pulido Olmo, H.
    Ruiz Hurtado, G.
    Schulz, A. M.
    Ruilope, L. M.
    Kolkhof, P.
    Somoza Hernandez, B.
    Kreutz, R.
    Fernandez Alfonso, M. S.
    JOURNAL OF HYPERTENSION, 2019, 37 : E89 - E90
  • [38] Chronic Kidney Disease as a Comorbidity in Heart Failure
    Szlagor, Magdalena
    Dybiec, Jill
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [39] Chronic kidney disease, heart failure and anemia
    Virani, Sean A.
    Khosla, Amit
    Levin, Adeera
    CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 : 22B - 24B
  • [40] Heart Disease and Kidney Failure in the Black Community
    Nicholas, Susanne B.
    Norris, Keith C.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (10) : 1764 - 1765
12345